Cytarabine

Back to search

Molecule Structure

Scientific Name

Cytarabine

Description of the Drug

Cytarabine is a pyrimidine nucleoside analogue used to treat acute non-lymphocytic leukemia, lymphocytic leukemia, and the blast phase of chronic myelocytic leukemia.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00987

Brand Name(s)

Alexan, Alexan 100, Cytarabine, Cytosar, Cytosar-u, Depocyt, Depocyte, Tarabine Pfs

Company Owner(s)

Hong Kong King Friend Industrial Co Ltd, Fresenius Kabi Usa Llc, Mylan Laboratories Ltd, Celator Pharmaceuticals Inc, West-Ward Pharmaceuticals International Ltd, Hospira Inc, Rising Pharma Holding Inc, Gland Pharma Ltd, Teva Parenteral Medicines Inc, Meitheal Pharmaceuticals Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
DNA polymerase (alpha/delta/epsilon) PROTEIN FAMILY INHIBITOR CHEMBL2363042
DNA NUCLEIC-ACID INHIBITOR CHEMBL2311221
RNA NUCLEIC-ACID INHIBITOR CHEMBL2311222

Unichem Links

Atlas cytarabine Ara-C
SureChEMBL SCHEMBL23152019 SCHEMBL22591193 SCHEMBL3140
PharmGKB PA449177
Human Metabolome Database HMDB0015122
DrugBank DB00987
PubChem: Thomson Pharma 15196510 14774115
PubChem 6253
Mcule MCULE-3945147956
NMRShiftDB 80001531
LINCS LSM-5470
Nikkaji J2.958K
PDBe AR3
BindingDB 50087289
EPA CompTox Dashboard DTXSID3022877
DrugCentral 770
Brenda 2016 18270 229322 148756 35304 32999 154421 92473 151038 206941 153431 229323 92471 2681 22093
Guide to Pharmacology 4827
rxnorm CYTARABINE LIPOSOME CYTARABINE
KEGG Ligand C02961
ChEBI 28680
ZINC ZINC000003795098